SOLV · Solventum Corporation

Healthcare NYQ United States solventum.com ↗
Val Gro Qua Mom Sta Cap P/S1.79 P/E Fwd P/E12.10 PEG1.22 52W –  RSI Target$93.92 (+7.4%) Beta0.69 Div
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Instruments & Supplies Eagan, United States 20,584 employees
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 46 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
5Bearish
0Neutral

Key Signals 1

▲ Double Bottom Major reversal 2026-07-16 · $80.6
Two lows ~$73.90 — bullish reversal confirmed
Learn more →

Momentum Signals 10

▲ Bull Flag 2026-06-03 · $77.82
▲ MACD Bullish Crossover 2026-06-04 · $82.42
▲ MACD Bullish Crossover 2026-07-16 · $81.7
▲ Bull Flag 2026-08-14 · $86.81

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Nov 05, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +7.4%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
8
5
2
BuyHoldSell
Price Target Range
$93.92 +7.4% upside
Low $70 High $113
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 54.78%Last 12 Months
Operating Margin 9.78%Last 12 Months
Return on Equity 33.96%Last 12 Months
Revenue Growth 2.20%Year over Year
Free Cash Flow 489.00MLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 110.31Most Recent Quarter
Current Ratio 1.02Most Recent Quarter
Cash 403.00MMost Recent Quarter
Total Debt 5.30BMost Recent Quarter
Net Debt Most Recent Quarter
How SOLV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap14.89B
Enterprise Value19.78B
Trailing P/E10.72
Forward P/E12.10
PEG Ratio (5yr)1.22
Price/Sales (ttm)1.79
Price/Book (mrq)3.10
EV/Revenue2.38
EV/EBITDA17.36
Share Statistics
Avg Vol (3m)1.17M
Shares Outstanding170.22M
Float144.09M
% Held by Insiders15.34%
% Held by Institutions75.89%
Short Ratio3.68
Short % of Float2.98%
Profitability
Gross Margin54.78%
Operating Margin (ttm)9.78%
Profit Margin17.26%
Return on Assets (ttm)2.70%
Return on Equity (ttm)33.96%
Income Statement
Revenue (ttm)8.31B
Revenue Growth (yoy)2.20%
Gross Profit (ttm)4.55B
EBITDA1.14B
Net Income (ttm)1.43B
Diluted EPS (ttm)8.16
EPS Growth (yoy)3.90%
Balance Sheet
Total Cash (mrq)403.00M
Total Debt (mrq)5.30B
Debt / Equity (mrq)110.31
Current Ratio (mrq)1.02
Book Value / Share28.22
Operating CF (ttm)209.00M
Free Cash Flow (ttm)489.00M
Trading & Dividends
Beta (5Y)0.69
50-Day MA84.67
200-Day MA77.56
Fwd Dividend YieldN/A
Payout Ratio0.00%

No dividend history available for SOLV.

Ownership Breakdown
Institutional 75.89% Insider 15.34% Public 8.8%
Short Interest 2.98% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in SOLV in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value